Generation Bio Co (GBIO) — Strategic Asset Allocation Index
Generation Bio Co (GBIO) has a Strategic Asset Allocation Index of 14.4% as of September 2024. Strategic assets (PP&E of $- plus long-term investments of $15.04 Million) total $15.04 Million, measured against net assets of $104.44 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Generation Bio Co Strategic Asset Allocation Index (2020–2022)
This chart shows how Generation Bio Co's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2024, the index stands at 14.4%, representing strategic assets of $15.04 Million against net assets of $104.44 Million USD. Explore GBIO cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Generation Bio Co (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Generation Bio Co from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Generation Bio Co worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 7.9% | $22.21 Million | $22.21 Million | $- | $282.49 Million | ▲ +1.1 pp |
| 2021 | 6.8% | $25.89 Million | $25.89 Million | $- | $381.75 Million | ▼ -2.1 pp |
| 2020 | 8.9% | $23.78 Million | $23.78 Million | $- | $268.01 Million | — |